[RGLS] QoQ Quarter Result on 30-Jun-2021 [#Q2]

Stock
[RGLS] Regulus Therapeutics Inc.
Announcement Date
10-Aug-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- -0.35%
YoY- 13.14%
Quarter Report
RGLS's Result
RGLS's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
Revenue 0 0 0 0 0 5,000 5,000 -
PBT -6,718 -7,133 -8,628 -6,033 -6,013 -1,315 -1,523 169.20%
Tax 1 214 1 1 -335 7 1 0.00%
NP -6,719 -7,133 -8,628 -6,034 -6,013 -1,322 -1,524 169.11%
Tax Rate - - - - - - - -
Total Cost 6,719 7,133 8,628 6,034 6,013 6,322 6,524 1.98%
Ratio Analysis
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 -26.44 -30.48 -
Per Share
31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 CAGR
EPS -0.46 -0.67 -0.99 -0.78 -0.84 -0.28 -0.40 9.77%
EPS Diluted -0.46 -0.67 -0.99 -0.78 -0.84 -0.28 -0.40 9.77%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.